NEW YORK (360Dx) – Beckman Coulter Diagnostics announced today that the US Food and Drug Administration has cleared the company's high-sensitivity troponin assay.

The Access hsTnI assay was cleared for use on Beckman Coulter's Access 2, Dxl, and the entire Access family of immunoassay systems. It detects troponin I, a protein present in circulation during myocardial infarction, to provide clinicians insight into life-threatening cardiac conditions in patients presenting with chest pain.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.